Weight loss and improvement of obesity-related illness following laparoscopic adjustable gastric banding procedure for morbidly obese patients in Taiwan

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background/Purpose: Laparoscopic adjustable gastric banding (LAGB) is a newly developed minimally invasive surgical procedure for the treatment of morbid obesity. This study was conducted to evaluate body weight loss, surgical complications, and comorbidities after LAGB surgery. Methods: Ninety-one morbidly obese patients (mean age, 31.2 years; mean preoperative weight, 120.8 kg) underwent LAGB in a private Taiwan hospital setting within a comprehensive multidisciplinary bariatric program. Patients were followed up to 36 months. Comorbidities were assessed in 55 patients who completed more than 12 months of follow-up by comparing each comorbid condition before surgery and during follow-up. Results: All procedures were performed laparoscopically with no conversion. Mean operation time was 88.7 ± 32.9 minutes. There were no intraoperative or major postoperative complications. Minor complication of stoma stenosis occurred in three (3.3%) patients. At 36 months after surgery, mean body mass index had decreased from 42.7 to 33.9 kg/m2, and mean percentage of excess weight loss was 44.8%. Late complications were as follows: intractable vomiting requiring band removal in one (1.1%) patient, tubing problems requiring revision surgery in four (4.3%), and stoma obstruction in two (2.1%). There was no mortality. Resolution or improvement of comorbidities was significant for hyperglycemia and diabetes-related index, dyslipidemia, abnormal liver function, hyperuricemia, sleep apnea, and arthralgia, but not for hypertension. Conclusion: LAGB provides good weight loss and significant reduction in comorbidities with few minor complications.

Original languageEnglish
Pages (from-to)887-894
Number of pages8
JournalJournal of the Formosan Medical Association = Taiwan yi zhi
Volume105
Issue number11
Publication statusPublished - Nov 2006
Externally publishedYes

Fingerprint

Taiwan
Weight Loss
Stomach
Obesity
Comorbidity
Bariatrics
Hyperuricemia
Private Hospitals
Minimally Invasive Surgical Procedures
Morbid Obesity
Sleep Apnea Syndromes
Arthralgia
Dyslipidemias
Reoperation
Hyperglycemia
Vomiting
Pathologic Constriction
Body Mass Index
Body Weight
Hypertension

Keywords

  • Gastric banding
  • Morbidly obesity
  • Obese-related illness

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{ed6c2864888e44da8234e777b5368781,
title = "Weight loss and improvement of obesity-related illness following laparoscopic adjustable gastric banding procedure for morbidly obese patients in Taiwan",
abstract = "Background/Purpose: Laparoscopic adjustable gastric banding (LAGB) is a newly developed minimally invasive surgical procedure for the treatment of morbid obesity. This study was conducted to evaluate body weight loss, surgical complications, and comorbidities after LAGB surgery. Methods: Ninety-one morbidly obese patients (mean age, 31.2 years; mean preoperative weight, 120.8 kg) underwent LAGB in a private Taiwan hospital setting within a comprehensive multidisciplinary bariatric program. Patients were followed up to 36 months. Comorbidities were assessed in 55 patients who completed more than 12 months of follow-up by comparing each comorbid condition before surgery and during follow-up. Results: All procedures were performed laparoscopically with no conversion. Mean operation time was 88.7 ± 32.9 minutes. There were no intraoperative or major postoperative complications. Minor complication of stoma stenosis occurred in three (3.3{\%}) patients. At 36 months after surgery, mean body mass index had decreased from 42.7 to 33.9 kg/m2, and mean percentage of excess weight loss was 44.8{\%}. Late complications were as follows: intractable vomiting requiring band removal in one (1.1{\%}) patient, tubing problems requiring revision surgery in four (4.3{\%}), and stoma obstruction in two (2.1{\%}). There was no mortality. Resolution or improvement of comorbidities was significant for hyperglycemia and diabetes-related index, dyslipidemia, abnormal liver function, hyperuricemia, sleep apnea, and arthralgia, but not for hypertension. Conclusion: LAGB provides good weight loss and significant reduction in comorbidities with few minor complications.",
keywords = "Gastric banding, Morbidly obesity, Obese-related illness",
author = "Lee, {Wei Jei} and Weu Wang and Wei, {Po Li} and Huang, {Ming Te}",
year = "2006",
month = "11",
language = "English",
volume = "105",
pages = "887--894",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "11",

}

TY - JOUR

T1 - Weight loss and improvement of obesity-related illness following laparoscopic adjustable gastric banding procedure for morbidly obese patients in Taiwan

AU - Lee, Wei Jei

AU - Wang, Weu

AU - Wei, Po Li

AU - Huang, Ming Te

PY - 2006/11

Y1 - 2006/11

N2 - Background/Purpose: Laparoscopic adjustable gastric banding (LAGB) is a newly developed minimally invasive surgical procedure for the treatment of morbid obesity. This study was conducted to evaluate body weight loss, surgical complications, and comorbidities after LAGB surgery. Methods: Ninety-one morbidly obese patients (mean age, 31.2 years; mean preoperative weight, 120.8 kg) underwent LAGB in a private Taiwan hospital setting within a comprehensive multidisciplinary bariatric program. Patients were followed up to 36 months. Comorbidities were assessed in 55 patients who completed more than 12 months of follow-up by comparing each comorbid condition before surgery and during follow-up. Results: All procedures were performed laparoscopically with no conversion. Mean operation time was 88.7 ± 32.9 minutes. There were no intraoperative or major postoperative complications. Minor complication of stoma stenosis occurred in three (3.3%) patients. At 36 months after surgery, mean body mass index had decreased from 42.7 to 33.9 kg/m2, and mean percentage of excess weight loss was 44.8%. Late complications were as follows: intractable vomiting requiring band removal in one (1.1%) patient, tubing problems requiring revision surgery in four (4.3%), and stoma obstruction in two (2.1%). There was no mortality. Resolution or improvement of comorbidities was significant for hyperglycemia and diabetes-related index, dyslipidemia, abnormal liver function, hyperuricemia, sleep apnea, and arthralgia, but not for hypertension. Conclusion: LAGB provides good weight loss and significant reduction in comorbidities with few minor complications.

AB - Background/Purpose: Laparoscopic adjustable gastric banding (LAGB) is a newly developed minimally invasive surgical procedure for the treatment of morbid obesity. This study was conducted to evaluate body weight loss, surgical complications, and comorbidities after LAGB surgery. Methods: Ninety-one morbidly obese patients (mean age, 31.2 years; mean preoperative weight, 120.8 kg) underwent LAGB in a private Taiwan hospital setting within a comprehensive multidisciplinary bariatric program. Patients were followed up to 36 months. Comorbidities were assessed in 55 patients who completed more than 12 months of follow-up by comparing each comorbid condition before surgery and during follow-up. Results: All procedures were performed laparoscopically with no conversion. Mean operation time was 88.7 ± 32.9 minutes. There were no intraoperative or major postoperative complications. Minor complication of stoma stenosis occurred in three (3.3%) patients. At 36 months after surgery, mean body mass index had decreased from 42.7 to 33.9 kg/m2, and mean percentage of excess weight loss was 44.8%. Late complications were as follows: intractable vomiting requiring band removal in one (1.1%) patient, tubing problems requiring revision surgery in four (4.3%), and stoma obstruction in two (2.1%). There was no mortality. Resolution or improvement of comorbidities was significant for hyperglycemia and diabetes-related index, dyslipidemia, abnormal liver function, hyperuricemia, sleep apnea, and arthralgia, but not for hypertension. Conclusion: LAGB provides good weight loss and significant reduction in comorbidities with few minor complications.

KW - Gastric banding

KW - Morbidly obesity

KW - Obese-related illness

UR - http://www.scopus.com/inward/record.url?scp=33845914743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845914743&partnerID=8YFLogxK

M3 - Article

VL - 105

SP - 887

EP - 894

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 11

ER -